Key facts
- This page summarizes Vishal Sikri's Form 4 filing for MYRIAD GENETICS INC (MYGN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 17 Sep 2026, 16:34.
Vishal Sikri - 16 Sep 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)
- Reporting relationship
- EVP, Commercial
- Issuer ticker
- MYGN
- Reported as of
- 16 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2026, 16:34:28 UTC
- Prior SEC filing
- 27 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- By: Justin Hunter For: Vishal Sikri
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Vishal Sikri filed Form 4 for MYRIAD GENETICS INC (MYGN) on 17 Sep 2026.
Change
- Previous filing in this sequence was filed on 27 Feb 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001931406
Primary reporting owner
Sikri Vishal
- Relationship
- EVP, Commercial
- Address
- 322 NORTH 2200 WEST, SALT LAKE CITY
- Signature
- By: Justin Hunter For: Vishal Sikri
- Signature date
- 17 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MYGN
transaction
Common Stock
Award
- Transaction value
- Shares
- +257,731
- Change %
- +276%
- Price
- $0.000000*
- Shares after
- 351,224
- Date
- 16 Sep 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.